Mass immunisation
with a newly developed vaccine against the coronavirus disease could start in
Switzerland in October, according to immunologist Martin Bachmann.
The national
regulatory body Swissmedic confirmed that it was in talks with scientists
including Bachmann, who works at the Bern University Hospital.
“The time schedule
is extremely optimistic, but it is not totally far-fetched,” Swissmedic
spokesman Lukas Jaggi told dpa this week.
“Given the urgency
of the coronavirus pandemic, we are talking about weeks, not months of approval
procedures,” he added.
If the vaccine meets
all requirements, a decision to green-light it could come before the end of the
year, according to the spokesman.
Bachmann told
journalists that he has already conducted successful tests using mice.
Bachmann used the
gene sequence of the Sars-CoV-2 virus that China published in January to
isolate proteins that allow the virus to latch on to human cells.
He then used this
genetic sequence to build a type of dummy virus that does not make people ill,
but that triggers an immune reaction that allows the body to fend off the real
virus.
Chinese and Latvian
partners are involved in the vaccine project.
Click to signup for FREE news updates, latest information and hottest gists everyday
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com